Global Drug Eluting Balloon for Peripheral Artery Disease Supply, Demand and Key Producers, 2026-2032
The global Drug Eluting Balloon for Peripheral Artery Disease market size is expected to reach $ 1799 million by 2032, rising at a market growth of 11.4% CAGR during the forecast period (2026-2032).
Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing ?limus? exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a ?leave nothing behind? concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability?often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD?supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.
The hurdle is no longer ?can you launch,? but ?can you scale with reproducibility and compliant delivery.? As drug?device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from ?operator preference?driven? toward ?pathway management?driven? growth?where evidence communication, technique standardization, and supply reliability matter more than ever.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or ?limus? agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.
This report studies the global Drug Eluting Balloon for Peripheral Artery Disease production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Balloon for Peripheral Artery Disease and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Balloon for Peripheral Artery Disease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Eluting Balloon for Peripheral Artery Disease total production and demand, 2021-2032, (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease total production value, 2021-2032, (USD Million)
Global Drug Eluting Balloon for Peripheral Artery Disease production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Drug Eluting Balloon for Peripheral Artery Disease consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Drug Eluting Balloon for Peripheral Artery Disease domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Balloon for Peripheral Artery Disease production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Drug Eluting Balloon for Peripheral Artery Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Balloon for Peripheral Artery Disease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Region:
1. How big is the global Drug Eluting Balloon for Peripheral Artery Disease market?
2. What is the demand of the global Drug Eluting Balloon for Peripheral Artery Disease market?
3. What is the year over year growth of the global Drug Eluting Balloon for Peripheral Artery Disease market?
4. What is the production and production value of the global Drug Eluting Balloon for Peripheral Artery Disease market?
5. Who are the key producers in the global Drug Eluting Balloon for Peripheral Artery Disease market?
6. What are the growth factors driving the market demand?
Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing ?limus? exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a ?leave nothing behind? concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability?often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD?supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.
The hurdle is no longer ?can you launch,? but ?can you scale with reproducibility and compliant delivery.? As drug?device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from ?operator preference?driven? toward ?pathway management?driven? growth?where evidence communication, technique standardization, and supply reliability matter more than ever.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or ?limus? agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.
This report studies the global Drug Eluting Balloon for Peripheral Artery Disease production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Balloon for Peripheral Artery Disease and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Balloon for Peripheral Artery Disease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Eluting Balloon for Peripheral Artery Disease total production and demand, 2021-2032, (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease total production value, 2021-2032, (USD Million)
Global Drug Eluting Balloon for Peripheral Artery Disease production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Drug Eluting Balloon for Peripheral Artery Disease consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Drug Eluting Balloon for Peripheral Artery Disease domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Balloon for Peripheral Artery Disease production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Drug Eluting Balloon for Peripheral Artery Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Balloon for Peripheral Artery Disease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Iliac Artery
- Femoropopliteal
- Other
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Hospitals
- Ambulatory Surgery Centers
- Catheterization Laboratories
- Others
- Medtronic
- Boston Scientific
- BD
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
1. How big is the global Drug Eluting Balloon for Peripheral Artery Disease market?
2. What is the demand of the global Drug Eluting Balloon for Peripheral Artery Disease market?
3. What is the year over year growth of the global Drug Eluting Balloon for Peripheral Artery Disease market?
4. What is the production and production value of the global Drug Eluting Balloon for Peripheral Artery Disease market?
5. Who are the key producers in the global Drug Eluting Balloon for Peripheral Artery Disease market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drug Eluting Balloon for Peripheral Artery Disease Introduction
1.2 World Drug Eluting Balloon for Peripheral Artery Disease Supply & Forecast
1.2.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021 & 2025 & 2032)
1.2.2 World Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.2.3 World Drug Eluting Balloon for Peripheral Artery Disease Pricing Trends (2021-2032)
1.3 World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (Based on Production Site)
1.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021-2032)
1.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2021-2032)
1.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2021-2032)
1.3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.3.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.3.6 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Eluting Balloon for Peripheral Artery Disease Major Market Trends
2 DEMAND SUMMARY
2.1 World Drug Eluting Balloon for Peripheral Artery Disease Demand (2021-2032)
2.2 World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region
2.2.1 World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region (2021-2026)
2.2.2 World Drug Eluting Balloon for Peripheral Artery Disease Consumption Forecast by Region (2027-2032)
2.3 United States Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.4 China Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.6 Japan Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.7 South Korea Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.8 ASEAN Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.9 India Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Manufacturer (2021-2026)
3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production by Manufacturer (2021-2026)
3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturer (2021-2026)
3.4 Drug Eluting Balloon for Peripheral Artery Disease Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug Eluting Balloon for Peripheral Artery Disease in 2025
3.5.3 Global Concentration Ratios (CR8) for Drug Eluting Balloon for Peripheral Artery Disease in 2025
3.6 Drug Eluting Balloon for Peripheral Artery Disease Market: Overall Company Footprint Analysis
3.6.1 Drug Eluting Balloon for Peripheral Artery Disease Market: Region Footprint
3.6.2 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Type Footprint
3.6.3 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison
4.1.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Comparison
4.2.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison
4.3.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.4.3 United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
4.5 China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share
4.5.1 China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.5.3 China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
4.6 Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Iliac Artery
5.2.2 Femoropopliteal
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2021-2032)
5.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2021-2032)
5.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2021-2032)
6.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2021-2032)
6.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Ambulatory Surgery Centers
8.2.3 Catheterization Laboratories
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2021-2032)
8.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2021-2032)
8.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.1.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Boston Scientific
9.2.1 Boston Scientific Details
9.2.2 Boston Scientific Major Business
9.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.2.4 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boston Scientific Recent Developments/Updates
9.2.6 Boston Scientific Competitive Strengths & Weaknesses
9.3 BD
9.3.1 BD Details
9.3.2 BD Major Business
9.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.3.4 BD Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 BD Recent Developments/Updates
9.3.6 BD Competitive Strengths & Weaknesses
9.4 Acotec
9.4.1 Acotec Details
9.4.2 Acotec Major Business
9.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.4.4 Acotec Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Acotec Recent Developments/Updates
9.4.6 Acotec Competitive Strengths & Weaknesses
9.5 Philips
9.5.1 Philips Details
9.5.2 Philips Major Business
9.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.5.4 Philips Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Philips Recent Developments/Updates
9.5.6 Philips Competitive Strengths & Weaknesses
9.6 Lepu Medical
9.6.1 Lepu Medical Details
9.6.2 Lepu Medical Major Business
9.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.6.4 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Lepu Medical Recent Developments/Updates
9.6.6 Lepu Medical Competitive Strengths & Weaknesses
9.7 Eurocor
9.7.1 Eurocor Details
9.7.2 Eurocor Major Business
9.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.7.4 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Eurocor Recent Developments/Updates
9.7.6 Eurocor Competitive Strengths & Weaknesses
9.8 MicroPort Medical
9.8.1 MicroPort Medical Details
9.8.2 MicroPort Medical Major Business
9.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.8.4 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 MicroPort Medical Recent Developments/Updates
9.8.6 MicroPort Medical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Chain
10.2 Drug Eluting Balloon for Peripheral Artery Disease Upstream Analysis
10.2.1 Drug Eluting Balloon for Peripheral Artery Disease Core Raw Materials
10.2.2 Main Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Drug Eluting Balloon for Peripheral Artery Disease Production Mode
10.6 Drug Eluting Balloon for Peripheral Artery Disease Procurement Model
10.7 Drug Eluting Balloon for Peripheral Artery Disease Industry Sales Model and Sales Channels
10.7.1 Drug Eluting Balloon for Peripheral Artery Disease Sales Model
10.7.2 Drug Eluting Balloon for Peripheral Artery Disease Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Drug Eluting Balloon for Peripheral Artery Disease Introduction
1.2 World Drug Eluting Balloon for Peripheral Artery Disease Supply & Forecast
1.2.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021 & 2025 & 2032)
1.2.2 World Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.2.3 World Drug Eluting Balloon for Peripheral Artery Disease Pricing Trends (2021-2032)
1.3 World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (Based on Production Site)
1.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021-2032)
1.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2021-2032)
1.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2021-2032)
1.3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.3.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.3.6 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Eluting Balloon for Peripheral Artery Disease Major Market Trends
2 DEMAND SUMMARY
2.1 World Drug Eluting Balloon for Peripheral Artery Disease Demand (2021-2032)
2.2 World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region
2.2.1 World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region (2021-2026)
2.2.2 World Drug Eluting Balloon for Peripheral Artery Disease Consumption Forecast by Region (2027-2032)
2.3 United States Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.4 China Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.6 Japan Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.7 South Korea Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.8 ASEAN Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
2.9 India Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Manufacturer (2021-2026)
3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production by Manufacturer (2021-2026)
3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturer (2021-2026)
3.4 Drug Eluting Balloon for Peripheral Artery Disease Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug Eluting Balloon for Peripheral Artery Disease in 2025
3.5.3 Global Concentration Ratios (CR8) for Drug Eluting Balloon for Peripheral Artery Disease in 2025
3.6 Drug Eluting Balloon for Peripheral Artery Disease Market: Overall Company Footprint Analysis
3.6.1 Drug Eluting Balloon for Peripheral Artery Disease Market: Region Footprint
3.6.2 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Type Footprint
3.6.3 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison
4.1.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Comparison
4.2.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison
4.3.1 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.4.3 United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
4.5 China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share
4.5.1 China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.5.3 China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
4.6 Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Iliac Artery
5.2.2 Femoropopliteal
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2021-2032)
5.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2021-2032)
5.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2021-2032)
6.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2021-2032)
6.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drug Eluting Balloon for Peripheral Artery Disease Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Ambulatory Surgery Centers
8.2.3 Catheterization Laboratories
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2021-2032)
8.3.2 World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2021-2032)
8.3.3 World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.1.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Boston Scientific
9.2.1 Boston Scientific Details
9.2.2 Boston Scientific Major Business
9.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.2.4 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boston Scientific Recent Developments/Updates
9.2.6 Boston Scientific Competitive Strengths & Weaknesses
9.3 BD
9.3.1 BD Details
9.3.2 BD Major Business
9.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.3.4 BD Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 BD Recent Developments/Updates
9.3.6 BD Competitive Strengths & Weaknesses
9.4 Acotec
9.4.1 Acotec Details
9.4.2 Acotec Major Business
9.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.4.4 Acotec Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Acotec Recent Developments/Updates
9.4.6 Acotec Competitive Strengths & Weaknesses
9.5 Philips
9.5.1 Philips Details
9.5.2 Philips Major Business
9.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.5.4 Philips Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Philips Recent Developments/Updates
9.5.6 Philips Competitive Strengths & Weaknesses
9.6 Lepu Medical
9.6.1 Lepu Medical Details
9.6.2 Lepu Medical Major Business
9.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.6.4 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Lepu Medical Recent Developments/Updates
9.6.6 Lepu Medical Competitive Strengths & Weaknesses
9.7 Eurocor
9.7.1 Eurocor Details
9.7.2 Eurocor Major Business
9.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.7.4 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Eurocor Recent Developments/Updates
9.7.6 Eurocor Competitive Strengths & Weaknesses
9.8 MicroPort Medical
9.8.1 MicroPort Medical Details
9.8.2 MicroPort Medical Major Business
9.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
9.8.4 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 MicroPort Medical Recent Developments/Updates
9.8.6 MicroPort Medical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Chain
10.2 Drug Eluting Balloon for Peripheral Artery Disease Upstream Analysis
10.2.1 Drug Eluting Balloon for Peripheral Artery Disease Core Raw Materials
10.2.2 Main Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Drug Eluting Balloon for Peripheral Artery Disease Production Mode
10.6 Drug Eluting Balloon for Peripheral Artery Disease Procurement Model
10.7 Drug Eluting Balloon for Peripheral Artery Disease Industry Sales Model and Sales Channels
10.7.1 Drug Eluting Balloon for Peripheral Artery Disease Sales Model
10.7.2 Drug Eluting Balloon for Peripheral Artery Disease Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021-2026) & (USD Million)
Table 3. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2027-2032) & (USD Million)
Table 4. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2021-2026)
Table 5. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2027-2032)
Table 6. World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2021-2026) & (K Units)
Table 7. World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2027-2032) & (K Units)
Table 8. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2021-2026)
Table 9. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2027-2032)
Table 10. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Drug Eluting Balloon for Peripheral Artery Disease Major Market Trends
Table 13. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region (2021-2026) & (K Units)
Table 15. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Drug Eluting Balloon for Peripheral Artery Disease Producers in 2025
Table 18. World Drug Eluting Balloon for Peripheral Artery Disease Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Drug Eluting Balloon for Peripheral Artery Disease Producers in 2025
Table 20. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease Company Evaluation Quadrant
Table 22. World Drug Eluting Balloon for Peripheral Artery Disease Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Drug Eluting Balloon for Peripheral Artery Disease Production Site of Key Manufacturer
Table 24. Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Type Footprint
Table 25. Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Application Footprint
Table 26. Drug Eluting Balloon for Peripheral Artery Disease Competitive Factors
Table 27. Drug Eluting Balloon for Peripheral Artery Disease New Entrant and Capacity Expansion Plans
Table 28. Drug Eluting Balloon for Peripheral Artery Disease Mergers & Acquisitions Activity
Table 29. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 37. China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 42. Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 47. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2021-2026) & (K Units)
Table 49. World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2027-2032) & (K Units)
Table 50. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2021-2026) & (USD Million)
Table 51. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2027-2032) & (USD Million)
Table 52. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2026) & (USD/Unit)
Table 60. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2027-2032) & (USD/Unit)
Table 61. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2026) & (USD/Unit)
Table 67. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2027-2032) & (USD/Unit)
Table 68. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2021-2026) & (K Units)
Table 70. World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2027-2032) & (K Units)
Table 71. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2021-2026) & (USD Million)
Table 72. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2027-2032) & (USD Million)
Table 73. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 78. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 82. Boston Scientific Major Business
Table 83. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 84. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boston Scientific Recent Developments/Updates
Table 86. Boston Scientific Competitive Strengths & Weaknesses
Table 87. BD Basic Information, Manufacturing Base and Competitors
Table 88. BD Major Business
Table 89. BD Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 90. BD Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. BD Recent Developments/Updates
Table 92. BD Competitive Strengths & Weaknesses
Table 93. Acotec Basic Information, Manufacturing Base and Competitors
Table 94. Acotec Major Business
Table 95. Acotec Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 96. Acotec Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Acotec Recent Developments/Updates
Table 98. Acotec Competitive Strengths & Weaknesses
Table 99. Philips Basic Information, Manufacturing Base and Competitors
Table 100. Philips Major Business
Table 101. Philips Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 102. Philips Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Philips Recent Developments/Updates
Table 104. Philips Competitive Strengths & Weaknesses
Table 105. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 106. Lepu Medical Major Business
Table 107. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 108. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Lepu Medical Recent Developments/Updates
Table 110. Lepu Medical Competitive Strengths & Weaknesses
Table 111. Eurocor Basic Information, Manufacturing Base and Competitors
Table 112. Eurocor Major Business
Table 113. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 114. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Eurocor Recent Developments/Updates
Table 116. Eurocor Competitive Strengths & Weaknesses
Table 117. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 118. MicroPort Medical Major Business
Table 119. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 120. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. MicroPort Medical Recent Developments/Updates
Table 122. MicroPort Medical Competitive Strengths & Weaknesses
Table 123. Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease Upstream (Raw Materials)
Table 124. Global Drug Eluting Balloon for Peripheral Artery Disease Typical Customers
Table 125. Drug Eluting Balloon for Peripheral Artery Disease Typical Distributors
Table 1. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2021-2026) & (USD Million)
Table 3. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Region (2027-2032) & (USD Million)
Table 4. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2021-2026)
Table 5. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2027-2032)
Table 6. World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2021-2026) & (K Units)
Table 7. World Drug Eluting Balloon for Peripheral Artery Disease Production by Region (2027-2032) & (K Units)
Table 8. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2021-2026)
Table 9. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2027-2032)
Table 10. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Drug Eluting Balloon for Peripheral Artery Disease Major Market Trends
Table 13. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Drug Eluting Balloon for Peripheral Artery Disease Consumption by Region (2021-2026) & (K Units)
Table 15. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Drug Eluting Balloon for Peripheral Artery Disease Producers in 2025
Table 18. World Drug Eluting Balloon for Peripheral Artery Disease Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Drug Eluting Balloon for Peripheral Artery Disease Producers in 2025
Table 20. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease Company Evaluation Quadrant
Table 22. World Drug Eluting Balloon for Peripheral Artery Disease Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Drug Eluting Balloon for Peripheral Artery Disease Production Site of Key Manufacturer
Table 24. Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Type Footprint
Table 25. Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Application Footprint
Table 26. Drug Eluting Balloon for Peripheral Artery Disease Competitive Factors
Table 27. Drug Eluting Balloon for Peripheral Artery Disease New Entrant and Capacity Expansion Plans
Table 28. Drug Eluting Balloon for Peripheral Artery Disease Mergers & Acquisitions Activity
Table 29. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Drug Eluting Balloon for Peripheral Artery Disease Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 37. China Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 42. Rest of World Based Drug Eluting Balloon for Peripheral Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share (2021-2026)
Table 47. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2021-2026) & (K Units)
Table 49. World Drug Eluting Balloon for Peripheral Artery Disease Production by Type (2027-2032) & (K Units)
Table 50. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2021-2026) & (USD Million)
Table 51. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type (2027-2032) & (USD Million)
Table 52. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Drug Eluting Balloon for Peripheral Artery Disease Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2026) & (USD/Unit)
Table 60. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2027-2032) & (USD/Unit)
Table 61. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Drug Eluting Balloon for Peripheral Artery Disease Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2026) & (USD/Unit)
Table 67. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2027-2032) & (USD/Unit)
Table 68. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2021-2026) & (K Units)
Table 70. World Drug Eluting Balloon for Peripheral Artery Disease Production by Application (2027-2032) & (K Units)
Table 71. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2021-2026) & (USD Million)
Table 72. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application (2027-2032) & (USD Million)
Table 73. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 78. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 82. Boston Scientific Major Business
Table 83. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 84. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boston Scientific Recent Developments/Updates
Table 86. Boston Scientific Competitive Strengths & Weaknesses
Table 87. BD Basic Information, Manufacturing Base and Competitors
Table 88. BD Major Business
Table 89. BD Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 90. BD Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. BD Recent Developments/Updates
Table 92. BD Competitive Strengths & Weaknesses
Table 93. Acotec Basic Information, Manufacturing Base and Competitors
Table 94. Acotec Major Business
Table 95. Acotec Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 96. Acotec Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Acotec Recent Developments/Updates
Table 98. Acotec Competitive Strengths & Weaknesses
Table 99. Philips Basic Information, Manufacturing Base and Competitors
Table 100. Philips Major Business
Table 101. Philips Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 102. Philips Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Philips Recent Developments/Updates
Table 104. Philips Competitive Strengths & Weaknesses
Table 105. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 106. Lepu Medical Major Business
Table 107. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 108. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Lepu Medical Recent Developments/Updates
Table 110. Lepu Medical Competitive Strengths & Weaknesses
Table 111. Eurocor Basic Information, Manufacturing Base and Competitors
Table 112. Eurocor Major Business
Table 113. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 114. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Eurocor Recent Developments/Updates
Table 116. Eurocor Competitive Strengths & Weaknesses
Table 117. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 118. MicroPort Medical Major Business
Table 119. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
Table 120. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. MicroPort Medical Recent Developments/Updates
Table 122. MicroPort Medical Competitive Strengths & Weaknesses
Table 123. Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease Upstream (Raw Materials)
Table 124. Global Drug Eluting Balloon for Peripheral Artery Disease Typical Customers
Table 125. Drug Eluting Balloon for Peripheral Artery Disease Typical Distributors
LIST OF FIGURES
Figure 1. Drug Eluting Balloon for Peripheral Artery Disease Picture
Figure 2. World Drug Eluting Balloon for Peripheral Artery Disease Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drug Eluting Balloon for Peripheral Artery Disease Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 5. World Drug Eluting Balloon for Peripheral Artery Disease Average Price (2021-2032) & (USD/Unit)
Figure 6. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2021-2032)
Figure 7. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2021-2032)
Figure 8. North America Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 9. Europe Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 10. Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 11. Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 14. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share by Region (2021-2032)
Figure 15. United States Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 16. China Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 17. Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 18. Japan Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 19. South Korea Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 21. India Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Drug Eluting Balloon for Peripheral Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Drug Eluting Balloon for Peripheral Artery Disease Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Drug Eluting Balloon for Peripheral Artery Disease Markets in 2025
Figure 25. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 29. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 31. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Type in 2025
Figure 33. Iliac Artery
Figure 34. Femoropopliteal
Figure 35. Other
Figure 36. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Type (2021-2032)
Figure 37. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Type (2021-2032)
Figure 38. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2032) & (USD/Unit)
Figure 39. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Use Scenario (2021-2032)
Figure 45. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2032) & (USD/Unit)
Figure 47. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2032) & (USD/Unit)
Figure 55. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Application in 2025
Figure 57. Hospitals
Figure 58. Ambulatory Surgery Centers
Figure 59. Catheterization Laboratories
Figure 60. Others
Figure 61. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Application (2021-2032)
Figure 62. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Application (2021-2032)
Figure 63. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2032) & (USD/Unit)
Figure 64. Drug Eluting Balloon for Peripheral Artery Disease Industry Chain
Figure 65. Drug Eluting Balloon for Peripheral Artery Disease Procurement Model
Figure 66. Drug Eluting Balloon for Peripheral Artery Disease Sales Model
Figure 67. Drug Eluting Balloon for Peripheral Artery Disease Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Drug Eluting Balloon for Peripheral Artery Disease Picture
Figure 2. World Drug Eluting Balloon for Peripheral Artery Disease Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drug Eluting Balloon for Peripheral Artery Disease Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 5. World Drug Eluting Balloon for Peripheral Artery Disease Average Price (2021-2032) & (USD/Unit)
Figure 6. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Region (2021-2032)
Figure 7. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Region (2021-2032)
Figure 8. North America Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 9. Europe Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 10. Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Production (2021-2032) & (K Units)
Figure 11. Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 14. World Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share by Region (2021-2032)
Figure 15. United States Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 16. China Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 17. Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 18. Japan Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 19. South Korea Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 21. India Drug Eluting Balloon for Peripheral Artery Disease Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Drug Eluting Balloon for Peripheral Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Drug Eluting Balloon for Peripheral Artery Disease Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Drug Eluting Balloon for Peripheral Artery Disease Markets in 2025
Figure 25. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Drug Eluting Balloon for Peripheral Artery Disease Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 29. China Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Production Market Share 2025
Figure 31. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Type in 2025
Figure 33. Iliac Artery
Figure 34. Femoropopliteal
Figure 35. Other
Figure 36. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Type (2021-2032)
Figure 37. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Type (2021-2032)
Figure 38. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2032) & (USD/Unit)
Figure 39. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Use Scenario (2021-2032)
Figure 45. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Use Scenario (2021-2032) & (USD/Unit)
Figure 47. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Balloon Platform Mechanics (2021-2032) & (USD/Unit)
Figure 55. World Drug Eluting Balloon for Peripheral Artery Disease Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Application in 2025
Figure 57. Hospitals
Figure 58. Ambulatory Surgery Centers
Figure 59. Catheterization Laboratories
Figure 60. Others
Figure 61. World Drug Eluting Balloon for Peripheral Artery Disease Production Market Share by Application (2021-2032)
Figure 62. World Drug Eluting Balloon for Peripheral Artery Disease Production Value Market Share by Application (2021-2032)
Figure 63. World Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2032) & (USD/Unit)
Figure 64. Drug Eluting Balloon for Peripheral Artery Disease Industry Chain
Figure 65. Drug Eluting Balloon for Peripheral Artery Disease Procurement Model
Figure 66. Drug Eluting Balloon for Peripheral Artery Disease Sales Model
Figure 67. Drug Eluting Balloon for Peripheral Artery Disease Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
